These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21059758)

  • 1. Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.
    Orestes P; Bojadzic D; Lee J; Leach E; Salajegheh R; Digruccio MR; Nelson MT; Todorovic SM
    J Physiol; 2011 Jan; 589(Pt 1):135-48. PubMed ID: 21059758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
    Barbara G; Alloui A; Nargeot J; Lory P; Eschalier A; Bourinet E; Chemin J
    J Neurosci; 2009 Oct; 29(42):13106-14. PubMed ID: 19846698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of interleukin-6 on Ca
    Liu Q; Chen W; Fan X; Wang J; Fu S; Cui S; Liao F; Cai J; Wang X; Huang Y; Su L; Zhong L; Yi M; Liu F; Wan Y
    Exp Neurol; 2019 Jul; 317():226-243. PubMed ID: 30872136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
    Howitt L; Kuo IY; Ellis A; Chaston DJ; Shin HS; Hansen PB; Hill CE
    Cardiovasc Res; 2013 Jun; 98(3):449-57. PubMed ID: 23436820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alteration of the metal/redox modulation of Cav3.2 T-type calcium channel reveals its role in neuronal excitability.
    Voisin T; Bourinet E; Lory P
    J Physiol; 2016 Jul; 594(13):3561-74. PubMed ID: 26931411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
    Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
    Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.
    Pudukulatham Z; Zhang FX; Gadotti VM; M'Dahoma S; Swami P; Tamboli Y; Zamponi GW
    Mol Pain; 2016; 12():. PubMed ID: 27053601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis.
    Shin SM; Cai Y; Itson-Zoske B; Qiu C; Hao X; Xiang H; Hogan QH; Yu H
    Mol Pain; 2020; 16():1744806920963807. PubMed ID: 33054557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. κ-Opioid receptor mediates the antinociceptive effect of nitrous oxide in mice.
    Fukagawa H; Koyama T; Fukuda K
    Br J Anaesth; 2014 Dec; 113(6):1032-8. PubMed ID: 25086587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of mu-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia.
    Koyama T; Mayahara T; Wakamatsu T; Sora I; Fukuda K
    Br J Anaesth; 2009 Nov; 103(5):744-9. PubMed ID: 19767313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromedin B receptor stimulation of Cav3.2 T-type Ca
    Zhang Y; Qian Z; Jiang D; Sun Y; Gao S; Jiang X; Wang H; Tao J
    Theranostics; 2021; 11(19):9342-9357. PubMed ID: 34646374
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone.
    Ayoola C; Hwang SM; Hong SJ; Rose KE; Boyd C; Bozic N; Park JY; Osuru HP; DiGruccio MR; Covey DF; Jevtovic-Todorovic V; Todorovic SM
    Psychopharmacology (Berl); 2014 Sep; 231(17):3503-3515. PubMed ID: 24800894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaV3.2 T-type Ca2+ channels mediate the augmented calcium influx in carotid body glomus cells by chronic intermittent hypoxia.
    Makarenko VV; Ahmmed GU; Peng YJ; Khan SA; Nanduri J; Kumar GK; Fox AP; Prabhakar NR
    J Neurophysiol; 2016 Jan; 115(1):345-54. PubMed ID: 26561606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca
    Tracy ME; Tesic V; Stamenic TT; Joksimovic SM; Busquet N; Jevtovic-Todorovic V; Todorovic SM
    Neuropharmacology; 2018 Jun; 135():343-354. PubMed ID: 29578032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of eugenol on T-type Ca2+ channel isoforms.
    Seo H; Li HY; Perez-Reyes E; Lee JH
    J Pharmacol Exp Ther; 2013 Nov; 347(2):310-7. PubMed ID: 24014106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
    Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S
    PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of Ca
    Matsui K; Tsubota M; Fukushi S; Koike N; Masuda H; Kasanami Y; Miyazaki T; Sekiguchi F; Ohkubo T; Yoshida S; Mukai Y; Oita A; Takada M; Kawabata A
    J Pharmacol Sci; 2019 Jul; 140(3):310-312. PubMed ID: 31492577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-type voltage gated calcium channels are involved in endothelium-dependent relaxation of mice pulmonary artery.
    Gilbert G; Courtois A; Dubois M; Cussac LA; Ducret T; Lory P; Marthan R; Savineau JP; Quignard JF
    Biochem Pharmacol; 2017 Aug; 138():61-72. PubMed ID: 28438566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2020 Nov; 887():173576. PubMed ID: 32949597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.